Latest news
Loading news…
Neurolutions
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Van Nuys, California, United States Founded 2007 11-50 employees For Profit
Neurolutions is a medical device company creating a revolutionary platform for neurorehabilitation leveraging BCI technology.
Neurolutions was acquired by Kandu Health in 2025.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
21
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $1M to $10M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 14
- Active products
- 23
- IT spend
- $9M
Company Info
- Founded
- 2007
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 21
- HQ
- Van Nuys, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
- Exit date
- Apr 8, 2025
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -0.9
- Trend (90d)
- -1
Key People at Neurolutions
Chief Operating Officer
21
professional contacts at Neurolutions
Contact execs at Neurolutions →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Neurolutions
Loading news…
FAQs about Neurolutions
People who checked this page also checked these
Browse the full Acquirezy directory.